Nanoparticles as Powerful Tools for Crossing the Blood-brain Barrier

Abstract

The blood-brain barrier (BBB) is considered an important protective barrier in the central nervous system (CNS). The barrier is mainly formed by endothelial cells (ECs) interconnected by various junctions such as tight junctions (TJs), gap junctions, and adherent junctions. They collectively constitute an intensive barrier to the transit of different substances into the brain, selectively permitting small molecules to pass through by passive movement but holding off large ones such as peptides and proteins to cross the brain. Hence some molecules selectively transfer across the BBB by active routes via transcytosis. The BBB also forms a barrier against neurotoxins as well as pathogenic agents. Although various CNS disorders like Alzheimer's disease (AD), and Parkinson's disease (PD) could hamper the integrity of the border. Nevertheless, the BBB acts as a barrier for CNS disorders treatment because it prevents the drugs from reaching their target in the CNS. In recent years, different strategies, including osmotic disruption of BBB or chemical modification of drugs, have been used to transfer the chemotherapeutic agents into brain substances. Nowadays, nanoparticles (NPs) have been used as an effective and non-invasive tool for drug delivery and diagnosis of CNS disorders. In this review, we discuss the structural characteristic of BBB, safe passageways to cross the BBB, and the relation of barrier lesions with different CNS disorders. In the end, we explore various progresses in drug delivery, diagnosis, imaging, and treatment of CNS disorders using nanoparticles.

Subaraknoid Kanamaya Bağlı Parkinson Hastalığının Karanlık Bir Nedeni Olarak Subtalamik Çekirdek Dejenerasyonu: Deneysel Bir Ön Çalışma

“…[6] Blood barrier disruption is an important stimulator on the development of Parkinson disease. [7] Blood brain barrier dysruptions vascular inflammation are observed in the basal ganglia in Parkinson's disease. [16,17] Magnetic resonance images detected atrophy in gray matter, amygdala, hippocampus and basal ganglia.…”

“…[24] What Our Study Suggests About the Etiology of Parkinson's Disease It is now certain that cerebral icemias disrupt the bloodbrain barrier. [7] If so; disruption of the blood-brain barrier as well as the collapse of the intelligence, military and civil defense systems of the brain; it means that it has become vulnerable to internal and external attacks. The blood flow of subthalamic nucleus is maintained by the perforforant branches of middle cerebral artery, posterior cerebral artery and anterior cerebral arteries in rats in order from most to least.…”

“…[6] Blood brain barrier disruption is an important stimulator on the development of Parkinson disease. [7] Magnetic resonance images detected gray matter, hippocampus, amygdala and basal ganglia atrophy. [8] The subthalamic nucleus is anatomically and functionally connected with important regions of brain such as cerebral cortex, basal ganglia, brainstem, limbic system and also spinal cord.…”

A Review of in vivo Toxicity of Quantum Dots in Animal Models

“…It has been proved that QDs were able to cross the blood–brain barrier and entered the central nervous system. 127 In addition, it was found that QDs are mainly transported from nose to brain through olfaction and transported through axons. 128 …”

Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases

“…Drugs that target AD or PD are needed to deliver across the blood-brain barrier (BBB) [ 11 , 12 ], which prevents 98% of neuropharmaceuticals from accessing the brain [ 13 ]. BBB contains brain capillary endothelial cells connected through tight junctions, which restricts paracellular transport and prevents the brain from harmful stimuli [ 14 , 15 , 16 ].…”